Prices delayed ≤15 min
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
Frequently Asked Questions about ABT
What does Abbott Laboratories (ABT) do?
Abbott Laboratories is a global healthcare company that specializes in discovering, developing, manufacturing, and selling health care products. It operates in four key segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. This diverse portfolio allows Abbott to cater to a wide range of healthcare needs worldwide.
Is ABT stock a good investment in 2026?
While specific valuation metrics are currently unavailable, Abbott Laboratories operates in the growing healthcare sector, which is expected to expand significantly. Investors may want to consider the company's historical performance and its focus on innovation in medical devices and diagnostics, which could drive future growth.
What is Abbott Laboratories's market capitalisation and stock price?
Currently, the market capitalisation and stock price of Abbott Laboratories are not available. However, it's important to look at the stock's performance over the past year, including its 52-week high and low, to gauge its trading range and market sentiment.
Does ABT pay dividends to shareholders?
Abbott Laboratories does not currently pay dividends to its shareholders. Instead, the company seems to focus on reinvesting its earnings into growth initiatives, particularly in its diverse healthcare segments.
How profitable is Abbott Laboratories?
Specific profitability metrics such as net income, net margin, and return on equity (ROE) are not available at this time. However, Abbott's diverse product segments typically contribute to a stable revenue stream, which can positively affect its overall profitability.
What is ABT's P/E ratio and is the stock overvalued?
Abbott Laboratories does not have a current P/E ratio available for analysis. However, considering the company's position in the healthcare sector, investors should compare its growth prospects with industry averages to determine if it may be overvalued.
How much debt does Abbott Laboratories have?
The current debt levels and debt-to-equity ratio for Abbott Laboratories are not provided. Investors should assess the company's balance sheet health and its ability to manage debt in relation to its cash flow and operational performance.
What is ABT's 52-week trading range?
The 52-week trading range for Abbott Laboratories is currently not disclosed. Investors should consider this range alongside the stock's moving averages to understand its volatility and market trends.
Is ABT a growth stock or value stock?
Without specific revenue growth and EPS growth data, it is difficult to classify Abbott Laboratories definitively. However, the company's focus on innovative healthcare solutions suggests it may lean towards being a growth stock in the medical devices industry.
What are the main risks of investing in ABT?
Investing in Abbott Laboratories carries certain risks, including its beta of 0.71, which indicates lower volatility compared to the market. Additionally, competition in the healthcare sector and potential regulatory challenges could impact the company's performance.